NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025
Details
- Buyer
- NHS England
- Published
- 17 February 2025
- Submission
- 7 April 2025
- Source
- uk:atamis:dhsc
Tender description
NHS Framework Agreement for Branded Medicines - Tranche B - MAE & NOFE - 01 September 2025 Offer reference number: CM/PHR/24/5680 CM/PHR/24/5680/01 - NHS Framework Agreement for North of England and Midlands & East - Tranche B Period of Framework Agreement: 01 September 2025 to 31 August 2027 CM/PHR/24/5680/02 - NHS Framework Agreement for Eculizumab and Ravulizumab for London and South of England Period of Framework Agreement: 01 September 2025 to 31 August 2027
Timeline
- Completed: Tender published17 February 2025Current notice
- Completed: Submission date7 April 2025
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
Related buyers
Buyers similar to NHS England.
- 455£2.1bn
- 367£249.3m
- 358£15.0bn
- 293£2.8bn
- 263£19.7bn
- 258£901.0m
- 247£509.3m
- 203£1.0bn
- 140£895.5m
- 115£59.6m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
